ทริพเพิล ไอ โลจิสติกส์ จับมือพันธมิตร ตั้งบริษัทลุยขนส่งวัคซีนโควิด

เว็บไซต์ www.thairath.co.th (วันที่ 13 มกราคม 2564)

ที่มา : https://www.thairath.co.th/news/business/stocks-gold/2012124?fbclid=IwAR28gsBXmu-pGnnWBO1dN38xKT8PZdEwrCnVQ3FbO6JDwDHEiGQOx6_aATg

Read more...

Triple i Logistics partners with global temperature control packaging firm Intelsius to deliver COVID-19 vaccines

Triple i Logistics Public Company Limited (III), a leading total logistics service provider in Thailand, is working with Intelsius, a global market leader in sample transport and temperature control packaging solutions, in its initiative to establish Cool Chain Logistics Pte., Ltd. (CCL) with the immediate mission to support the delivery of COVID-19 vaccines, test-kits and other materials, with a clear focus in the Asia-Pacific region.

Mr. Tipp Dalal, CEO of Triple i Logistics, said “Based on the company’s business strategy for 2019-2021, ¬we will be expanding investment in our international logistics business (air, sea and land), especially in the transportation of critical life-saving materials such as medicines and vaccines.”

The new company, Cool Chain Logistics recently reached a supply & services agreement with Intelsius for the provision and service support of its proprietary ORCA VIP High performance reusable packaging systems. This will help the rapid deployment and development of Cool Chain Logistics services to provide specialist logistical services for drugs and medical equipment related to the novel coronavirus 2019 (COVID-19).

Mr. Tipp commented “This is a fantastic business opportunity for Triple i Logistics, with our focus on supporting the Covid-19 vaccination distribution efforts in Asia by offering our intra-Asia logistics services using validated cold chain systems with real time track and trace and online temperature monitoring.”

Cool Chain Logistics Pte., Ltd. is headquartered in Singapore and will provide comprehensive logistics specific to the Life Science industry transporting shipments such as temperature sensitive biopharmaceuticals, biological substances, and medical devices under the cooperation of a network of international partners.

Read more...